The lipodystrophy syndromes practice guidelines remind us that in patients with atypical progeroid syndromes and FPLD2 due to LMNA mutations, cardiac abnormalities including ischemic heart disease, cardiomyopathy, arrhythmias and sudden death are reported [58]. The gene discussed is LMNA; the disease is coronary artery disorder.